Focus on melanoma

Cancer Cell

Volumn 2, Issue 4, 2002, Pages 275-278

  Houghton, Alan N ^a   Polsky, David ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; AZACITIDINE; CANCER VACCINE; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CELL CYCLE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG MECHANISM; FAMILIAL CANCER; GENE; HUMAN; MELANOMA; MUTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; ULTRAVIOLET RADIATION; CELL TRANSFORMATION; DRUG EFFECT; GENETICS; MELANOCYTE; PATHOLOGY; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SKIN TUMOR;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; MUTATION; RISK FACTORS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 0036780566     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00161-7     Document Type: Review

References (27)

1. Albino, A.P., Sozzi, G., Nanus, D.M., Jhanwar, S.C., and Houghton, A.N. (1992). Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene 7, 2315-2321.
2. Balch, C., Houghton, A., Sober, A., and Soong, S.-j. (2002). Cutaneous Melanoma, Fourth Edition (St. Louis, MO: Quality Medical Publishing).
3. Bardeesy, N., Wong, K.K., DePinho, R.A., and Chin, L. (2000). Animal models of melanoma: recent advances and future prospects. Adv. Cancer Res. 79, 123-156.
4. Bardeesy, N., Bastian, B.C., Hezel, A., Pinkel, D., DePinho, R.A., and Chin, L. (2001). Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol. Cell. Biol. 21, 2144-2153.
5. Berwick, M., and Halpern, A. (1997). Melanoma epidemiology. Curr. Opin. Oncol. 9, 178-182.
6. Bishop, D.T., Demenais, F., Goldstein, A.M., Bergman, W., Bishop, J.N., Bressac-de Paillerets, B., Chompret, A., Ghiorzo, P., Gruis, N., Hansson, J., et al. (2002). Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl. Cancer Inst. 94, 894-903.
7. Cannon-Albright, L.A., Goldgar, D.E., Meyer, L.J., Lewis, C.M., Anderson, D.E., Fountain, J.W., Hegi, M.E., Wiseman, R.W., Petty, E.M., Bale, A.E., et al. (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258, 1148-1152.
8. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999). Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468-472.
9. Clark, E.A., Golub, T.R., Lander, E.S., and Hynes, R.O. (2000). Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535.
10. Clark, W.H., Jr., From, L., Bernardino, E.A., and Mihm, M.C. (1969).The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 29, 705-727.
11. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., et al. (2002). Mutations of the BRAF gene in human cancer. Nature 477, 949-954.
12. Fountain, J.W., Karayiorgou, M., Ernstoff, M.S., Kirkwood, J.M., Vlock, D.R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A.N., Lahti, J., et al. (1992). Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci. USA 89, 10557-10561.
13. Houghton, A.N., and Viola, M.V. (1981). Solar radiation and malignant melanoma of the skin. J. Am. Acad. Dermatol. 5, 477-483.
14. Houghton, A.N., Gold, J.S., and Blachere, N.E. (2001). Immunity against cancer: lessons learned from melanoma. Curr. Opin. Immunol. 13, 134-140.
15. Kripke, M.L. (1991). Immunological effects of ultraviolet radiation. J. Dermatol. 18, 429-433.
16. Lynch, H.T., Anderson, D.E., Smith, J.L., Jr., Howell, J.B., and Krush, A.J. (1967). Xeroderma pigmentosum, malignant melanoma, and congenital ichthyosis. A family study. Arch. Dermatol. 96, 625-635.
17. Noonan, F.P., Recio, J.A., Takayama, H., Duray, P., Anver, M.R., Rush, W.L., De Fabo, E.C., and Merlino, G. (2001). Neonatal sunburn and melanoma in mice. Nature 413, 271-272.
18. Oliveria, S., Dusza, S., and Berwick, M. (2001). Issues in the epidemiology of melanoma. Expert Rev. Anticancer Ther. 1, 453-459.
19. Polsky, D., Bastian, B.C., Hazan, C., Melzer, K., Pack, J., Houghton, A., Busam, K., Cordon-Cardo, C., and Osman, I. (2001a). HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. Cancer Res. 61, 7642-7646.
20. Polsky, D., Cordon-Cardo, C., and Houghton, A. (2001b). Molecular biology of melanoma, In The Molecular Basis of Cancer, Mendelson, J., Howley, P.M., Israel, M.A., and Liotta, L.A., eds (Philadelphia: W.B. Saunders Company).
21. Polsky, D., Young, A.Z., Busam, K.J., and Alani, R.M. (2001c). The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 61, 6008-6011.
22. Sauter, E.R., Yeo, U.C., von Stemm, A., Zhu, W., Litwin, S., Tichansky, D.S., Pistritto, G., Nesbit, M., Pinkel, D., Herlyn, M., and Bastian, B.C. (2002). Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 62, 3200-3206.
23. Soengas, M.S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J.G., Gerald, W.L., Lazebnik, Y.A., et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-211.
24. Sotillo, R., Garcia, J.F., Ortega, S., Martin, J., Dubus, P., Barbacid, M., and Malumbres, M. (2001). Invasive melanoma in Cdk4-targeted mice. Proc. Natl. Acad. Sci. USA 98, 13312-13317.
25. Vijayasaradhi, S., Xu, Y., Bouchard, B., and Houghton, A.N. (1995). Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J. Cell Biol. 130, 807-820.
26. Wang, S.Q., Setlow, R., Berwick, M., Polsky, D., Marghoob, A.A., Kopf, A.W., and Bart, R.S. (2001). Ultraviolet A and melanoma: a review. J. Am. Acad. Dermatol. 44, 837-846.
27. Zuo, L., Weger, J., Yang, Q., Goldstein, A.M., Tucker, M.A., Walker, G.J., Hayward, N., and Dracopoli, N.C. (1996). Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12, 97-99.